October 10, 2011
MediciNova, Inc. of the US announced on September 27 a private offering of common stock and Series B convertible preferred stock to Kissei Pharmaceutical. Proceeds from the sale of shares will be US$7.5 million (approximately ¥575 million) and will be...read more